Trends in molecular medicine

New findings on the gut microbiome's links to autism

Updated

Abstract

Gut dysbiosis is associated with autism spectrum disorder (ASD).

  • Alterations in gut microbiota may influence brain function.
  • Gut microbiota could serve as potential diagnostic biomarkers for ASD.
  • The role of gut microbiota is discussed in relation to ASD pathogenesis.
  • Therapeutic targeting of gut microbiota may be a viable approach for ASD.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of interests S.C.N. has served as an advisory board member for Pfizer, Ferring, Janssen, and Abbvie, and has received honoraria as a speaker for Ferring, Tillotts, Menarini, Janssen, Abbvie, and Takeda. S.C.N. has received research grants through her affiliated institutions from Olympus, Ferring, and Abbvie. S.C.N. is a founder member, non-executive director, non-executive scientific advisor, and shareholder of GenieBiome Ltd. S.C.N. receives patent royalties through her affiliated institutions. Q.S. is a Scientist (Diagnostics) of GenieBiome Ltd. Y.W., Q.S., and S.C.N. are named inventors of patent applications held by the CUHK and MagIC that cover the therapeutic and diagnostic use of microbiomes related to ASD.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free